SBF AG (CY1K.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:CY1K • DE000A2AAE22

4.52 EUR
-0.14 (-3%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

CY1K gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 67 industry peers in the Electrical Equipment industry. CY1K scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CY1K is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CY1K has reported negative net income.
  • CY1K had a negative operating cash flow in the past year.
  • In multiple years CY1K reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: CY1K reported negative operating cash flow in multiple years.
CY1K.DE Yearly Net Income VS EBIT VS OCF VS FCFCY1K.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M -8M

1.2 Ratios

  • The Return On Assets of CY1K (-4.03%) is worse than 65.67% of its industry peers.
  • CY1K has a worse Return On Equity (-6.32%) than 62.69% of its industry peers.
Industry RankSector Rank
ROA -4.03%
ROE -6.32%
ROIC N/A
ROA(3y)-4.25%
ROA(5y)1.07%
ROE(3y)-6.03%
ROE(5y)2.13%
ROIC(3y)N/A
ROIC(5y)N/A
CY1K.DE Yearly ROA, ROE, ROICCY1K.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • CY1K has a Gross Margin of 47.99%. This is in the better half of the industry: CY1K outperforms 70.15% of its industry peers.
  • CY1K's Gross Margin has declined in the last couple of years.
  • CY1K does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.52%
GM growth 5Y-3.06%
CY1K.DE Yearly Profit, Operating, Gross MarginsCY1K.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • CY1K does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CY1K remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CY1K has more shares outstanding
  • CY1K has a better debt/assets ratio than last year.
CY1K.DE Yearly Shares OutstandingCY1K.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CY1K.DE Yearly Total Debt VS Total AssetsCY1K.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 3.33 indicates that CY1K is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.33, CY1K is doing good in the industry, outperforming 68.66% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that CY1K is not too dependend on debt financing.
  • CY1K has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. CY1K outperforms 94.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.33
ROIC/WACCN/A
WACC8.72%
CY1K.DE Yearly LT Debt VS Equity VS FCFCY1K.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 5.56 indicates that CY1K has no problem at all paying its short term obligations.
  • CY1K has a better Current ratio (5.56) than 98.51% of its industry peers.
  • CY1K has a Quick Ratio of 2.04. This indicates that CY1K is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CY1K (2.04) is better than 86.57% of its industry peers.
Industry RankSector Rank
Current Ratio 5.56
Quick Ratio 2.04
CY1K.DE Yearly Current Assets VS Current LiabilitesCY1K.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 40.00% over the past year.
  • The Revenue has grown by 38.99% in the past year. This is a very strong growth!
  • The Revenue has been growing by 22.84% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.52%
Revenue 1Y (TTM)38.99%
Revenue growth 3Y14.83%
Revenue growth 5Y22.84%
Sales Q2Q%42.09%

3.2 Future

  • Based on estimates for the next years, CY1K will show a very strong growth in Earnings Per Share. The EPS will grow by 67.11% on average per year.
  • CY1K is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.51% yearly.
EPS Next Y91.67%
EPS Next 2Y90.39%
EPS Next 3Y67.11%
EPS Next 5YN/A
Revenue Next Year-7.67%
Revenue Next 2Y3.19%
Revenue Next 3Y5.07%
Revenue Next 5Y6.51%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CY1K.DE Yearly Revenue VS EstimatesCY1K.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M
CY1K.DE Yearly EPS VS EstimatesCY1K.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CY1K. In the last year negative earnings were reported.
  • Also next year CY1K is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CY1K.DE Price Earnings VS Forward Price EarningsCY1K.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CY1K is valued a bit more expensive than the industry average as 70.15% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 120.79
CY1K.DE Per share dataCY1K.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CY1K's earnings are expected to grow with 67.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.39%
EPS Next 3Y67.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CY1K!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SBF AG

FRA:CY1K (2/6/2026, 7:00:00 PM)

4.52

-0.14 (-3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)10-15
Earnings (Next)N/A
Inst Owners11.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap43.89M
Revenue(TTM)47.20M
Net Income(TTM)-1.99M
Analysts86.67
Price Target9.04 (100%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10.3%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-100%
EPS NY rev (3m)-150%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.93
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB 1.4
EV/EBITDA 120.79
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS4.86
BVpS3.24
TBVpS3.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.03%
ROE -6.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.99%
FCFM N/A
ROA(3y)-4.25%
ROA(5y)1.07%
ROE(3y)-6.03%
ROE(5y)2.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.52%
GM growth 5Y-3.06%
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.02
Cap/Depr 68.48%
Cap/Sales 2.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.56
Quick Ratio 2.04
Altman-Z 3.33
F-Score5
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)99.31%
Cap/Depr(5y)148.34%
Cap/Sales(3y)5.49%
Cap/Sales(5y)6.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.52%
EPS Next Y91.67%
EPS Next 2Y90.39%
EPS Next 3Y67.11%
EPS Next 5YN/A
Revenue 1Y (TTM)38.99%
Revenue growth 3Y14.83%
Revenue growth 5Y22.84%
Sales Q2Q%42.09%
Revenue Next Year-7.67%
Revenue Next 2Y3.19%
Revenue Next 3Y5.07%
Revenue Next 5Y6.51%
EBIT growth 1Y53.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year261.24%
EBIT Next 3Y126.14%
EBIT Next 5Y72.84%
FCF growth 1Y-112.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-343.31%
OCF growth 3YN/A
OCF growth 5YN/A

SBF AG / CY1K.DE FAQ

What is the ChartMill fundamental rating of SBF AG (CY1K.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CY1K.DE.


What is the valuation status of SBF AG (CY1K.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to SBF AG (CY1K.DE). This can be considered as Overvalued.


What is the profitability of CY1K stock?

SBF AG (CY1K.DE) has a profitability rating of 1 / 10.


Can you provide the financial health for CY1K stock?

The financial health rating of SBF AG (CY1K.DE) is 6 / 10.


Can you provide the expected EPS growth for CY1K stock?

The Earnings per Share (EPS) of SBF AG (CY1K.DE) is expected to grow by 91.67% in the next year.